Baloxavir Marboxil-impurities | Pharmaffiliates

Baloxavir Marboxil

Baloxavir marboxil (BXM), sold under the brand name Xofluza, is an antiviral medication for treatment of influenza A and influenza B. medication.Baloxavir marboxil is an antiviral drug developed by Shionogi Co, a Japanese pharmaceutical company and Roche for the treatment of influenza A and influenza B infections. Reference standards of Baloxavir Marboxil API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => 3,4-Difluorobenzoic Acid (BSC)
    [catalogue_number] => PA BSC 19502582
    [category_ids] => ,169,
    [chemical_name] => 
    [weight] => 158.1
    [form] => C7H4F2O2
    [cas] => 455-86-7
    [pslug] => 455-86-7-3-4-difluorobenzoic-acid-bsc-pabsc19502582
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA BSC 19502582

3,4-Difluorobenzoic Acid (BSC)


  • Catalogue No.:PA BSC 19502582

  • CAS :

    455-86-7

  • Molecular Formula : C7H4F2O2

  • Molecular Weight : 158.1